SCHEMBL8324910

SCHEMBL8324910

C/C=C(/CC)c1ccc(OC)c(C=O)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 1/20 0.47
ALDH1A1 P00352 4/20 0.44
TSHR P16473 2/20 0.44
KDM4E B2RXH2 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
TUBB1 Q9H4B7 2/20 0.43
AOX1 Q06278 1/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA4 P22748 1/20 0.41
CA6 P23280 1/20 0.41
CA7 P43166 1/20 0.41
TPMT P51580 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAOB P27338 1/20 0.41
PTGS1 P23219 1/20 0.40
ERN1 O75460 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8320882 0.84 GAA (0.42) ALDH1A1KDM4ETDP1L3MBTL1ERN1
SCHEMBL4585814 0.82 NQO2 (0.65) NQO2TSHRKDM4ETUBB1CA12
SCHEMBL4585826 0.82 NQO2 (0.65) NQO2TSHRKDM4ETUBB1CA12
SCHEMBL4585821 0.82 NQO2 (0.65) NQO2TSHRKDM4ETUBB1CA12
SCHEMBL14613395 0.80 PDE4A (0.54) NQO2ALDH1A1TSHRTUBB1AOX1
SCHEMBL3850273 0.80 ERN1 (0.47) ERN1
SCHEMBL3850277 0.80 ERN1 (0.47) ERN1
SCHEMBL29956605 0.78 CA12 (0.67) ALDH1A1TSHRKDM4ETDP1CA12
SCHEMBL1987664 0.78 CA12 (0.67) ALDH1A1TSHRKDM4ETDP1CA12
SCHEMBL8248745 0.78 MAOB (0.71) ALDH1A1TSHRKDM4ETDP1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004073638-A2 METHOD OF LOWERING BODY TEMPERATURE WITH (S)-2,3-BENZODIAZEPINES VELA PHARMACEUTICALS, INC. (US) 2004-09-02 WO disclosed
WO-2004050616-A2 TREATMENT OF IRRITABLE BOWEL SYNDROME AND NONULCER DYSPEPSIA WITH SUBSTITUTED 2,3-BENZODIAZEPINES VELA PHARMACEUTICALS, INC. (US) 2004-06-17 WO disclosed